Chapter 44. Treatment of Fulminant Hepatitis

  1. Howard Thomas BSc PhD FRCP FRCpath FMedSci Professor1,
  2. Stanley Lemon Professor2 and
  3. Arie Zuckerman MD, DSc, FRCP, FRCPath, FMedSci, Dip. Bact Professor3
  1. Kinan Rifai,
  2. Hans L Tillmann and
  3. Michael P Manns

Published Online: 26 OCT 2007

DOI: 10.1002/9780470987131.ch44

Viral Hepatitis, Third Edition

Viral Hepatitis, Third Edition

How to Cite

Rifai, K., Tillmann, H. L. and Manns, M. P. (2005) Treatment of Fulminant Hepatitis, in Viral Hepatitis, Third Edition (eds H. Thomas, S. Lemon and A. Zuckerman), Blackwell Publishing Ltd, Oxford, UK. doi: 10.1002/9780470987131.ch44

Editor Information

  1. 1

    Dean (Clinical) Faculty of Medicine, Imperial College, Department of Medicine, Queen Elizabeth Queen Mother Wing, St Mary's Hospital Medical School, London UK

  2. 2

    Dean of Medicine, Department of Microbiology & Immunology & Internal Medicine, University of Texas Medical Branch, Galveston, Texas, USA

  3. 3

    The Royal Free Hospital of Medicine, Rowland Hill Street, London, UK

Publication History

  1. Published Online: 26 OCT 2007
  2. Published Print: 12 JUL 2005

ISBN Information

Print ISBN: 9781405130059

Online ISBN: 9780470987131



  • fulminant hepatic failure;
  • acute liver failure (ALF);
  • hepatitis A virus (HAV);
  • hepatitis C virus (HCV);
  • hepatic encephalopathy


This chapter contains sections titled:

  • Definition of fulminant hepatitis

  • Aetiology of fulminant hepatitis

  • Complications in fulminant hepatitis

  • Specific therapy in fulminant hepatitis

  • Prognosis, liver transplantation and alternative procedures

  • Conclusion